Key Players
- Angion
- Mandalmed
- G3 pharmaceuticals
- Galectin Therapeutics
- GlycoMimetics Inc.
- Galecto Biotech
- iTeos Therapeutics
- Novartis International AG
- Pfizer Inc.
- Eli Lilly
Galectin Inhibitor Therapeutics Market
Starting at US$ 5000
Buy Now
Industry
Media
Contact
